R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. (Q46302136)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. |
scientific article |
Statements
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study (English)
Alejandro MartÃn
Eulogio Conde
Montserrat Arnan
Miguel A Canales
Guillermo Deben
Rafael Andreu
Pedro GarcÃa-Sanchez
Lourdes Vázquez
Sara Nistal
MarÃa-José Requena
Eva M Donato
José A González
Angel León
Concepción Ruiz
Carlos Grande
MarÃa-Dolores Caballero
Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Cooperative Group)
22 October 2008